PHARMACEUTICAL PREPARATION FOR THE TREATMENT OF BETA O STREPTOCOCCAL TONSILLITIS

摘要

A pharmaceutical preparation in the prophylaxis against and/or the treatment of beta -streptococcal tonsillitis is described. The preparation includes at least one viable microorganism strain selected from the group consisting of Streptococcus sanguis II strains with the deposit numbers NCIB 40104, NCIB 40105 and NCIB 40106, the Streptococcus mitis strain with the deposit number NCIB 40107 and streptococci strains with essentially the same capacity to inhibit beta -streptococci as the deposited strains, in a pharmaceutically acceptable medium wherein the microorganisms retain their viability. Use of the preparation in the prophylaxis against and/or the treatment of beta -streptococcal tonsillitis is also described.